P090 | ACUTE MYELOID LEUKEMIA TREATED WITH VENETOCLAX IN COMBINATION WITH HYPOMETHYLATING AGENTS: A RETROSPECTIVE, MONOCENTRIC STUDY.
According to the most recent European Leukemia Net guidelines, the association of venetoclax (VEN) plus hypomethylating agents (HMAs) is considered the standard-of-care for patients with acute myeloid leukemia (AML) unfit for intensive chemotherapy (IC). We collected data of AML patients treated wi...
Furkejuvvon:
| Váldodahkkit: | , , , , , , , |
|---|---|
| Materiálatiipa: | Artigo |
| Giella: | Inglês |
| Almmustuhtton: |
Ferrata Storti Foundation
2025-09-01
|
| Ráidu: | Haematologica |
| Liŋkkat: | https://haematologica.org/article/view/12487 |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|